CG

Chris Garabedian

CEO, Xontogeny and Portfolio Manager, PXV Fund

Boston, Massachusetts

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $1,000,000.00

Skills

Biopharmaceuticals
Drug Development
Biotechnology
Product Management
Pharmaceutical Industry
Infectious Diseases
Strategy
Life Sciences
Market Research
Regulatory Affairs
Oncology
Clinical Trials
Product Launch
Strategic Planning
Clinical Development
Product Development
Technology Transfer
Vaccines
Drug Discovery
Marketing Strategy

Education

Work Experience

  • Chairman and CEO

    2016

  • Portfolio Manager, Venture (PXV Fund)

    2017

  • Board Member

    2020

  • Board Member

    2020

  • Board Member

    2020

Landos Biopharma, Inc.

2017 - 2024

  • Chairman of the Board

    2017 - 2024

2020 - 2023

  • Chairman of the Board

    2020 - 2023

  • Senior Advisor to Healthcare Practice

    2016 - 2021

Quellis Biosciences

2017 - 2021

  • Chairman of the Board

    2017 - 2021

  • Chief Executive Officer

    2011 - 2015